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Abstract
Background: Our laboratories have previously reported on the experimental infection of cattle
with Mycobacterium avium subsp paratuberculosis (M. paratuberculosis) using an intratonsillar infection
model. In addition, we have recently developed a partial protein array representing 92 M.
paratuberculosis  coding sequences. These combined tools have enabled a unique look at the
temporal analysis of M. paratuberculosis antigens within the native host. The primary objective of
this study was to identify M. paratuberculosis antigens detected by cattle early during infection. A
secondary objective was to evaluate the humoral immune response in cattle during the initial year
of infection.
Results: Sera from two experimentally infected cattle, taken pre-inoculation and at day 70, 194
and 321 post infection, identified dynamic antibody reactivity among antigens with some showing
an increased response over time and others showing declining levels of reactivity over the same
time period. A M. paratuberculosis specific protein, encoded by MAP0862, was strongly detected
initially, but the antibody response became weaker with time. The most reactive protein was a
putative surface antigen encoded by MAP1087. A second protein, MAP1204, implicated in
virulence, was also strongly detected by day 70 in both cattle. Subsequent experiments showed that
these two proteins were detected with sera from 5 of 9 naturally infected cattle in the subclinical
stage of Johne's disease.
Conclusion: Collectively these results demonstrate that M. paratuberculosis proteins are detected
by sera from experimentally infected cattle as early as 70 days after exposure. These data further
suggest at least two antigens may be useful in the early diagnosis of M. paratuberculosis infections.
Finally, the construction and use of a protein array in this pilot study has led to a novel approach
for discovery of M. paratuberculosis antigens.
Background
Johne's disease is an economically significant intestinal
disease caused by Mycobacterium avium subsp paratubercu-
losis (M. paratuberculosis). A recent survey estimated that
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20%–40% of dairy herds in the United States are infected
with  M. paratuberculosis and producers lose $227 USD
annually for each infected animal [1]. These costs are
mostly attributed to the decreased milk production and
weight loss resulting from the disease.
After M. paratuberculosis infection by ingestion of contam-
inated milk or grass containing fecal material from a shed-
ding cow, there is a lengthy subclinical phase that can last
for several years. During this stage the cows may appear
healthy, but can intermittently shed low numbers of
mycobacteria in the feces, enabling transmission to other
animals including wildlife species. A major challenge in
controlling Johne's disease is the ability to detect infected
cattle prior to appearance of disease signs, such as
diarrhea and heavy fecal shedding of M. paratuberculosis.
An unknown trigger, possibly stress during lactation or
parturition, advances the disease from subclinical to clin-
ical where disease signs such as weight loss and diarrhea
become evident [2,3]. This trigger appears to coincide
with a shift in immune function from a Th1 response to a
Th2 response [4]. Current detection of subclinical animals
depends on the timing and sensitivity of the test. Even the
most sensitive culture-based tests will not detect M.
paratuberculosis  if a subclinically infected animal is not
shedding bacilli at the time the fecal or milk sample is col-
lected.  M. paratuberculosis antigen induced interferon
(IFN)-γ has been shown to be elevated in subclinical ani-
mals, but this cytokine declines in the clinical stage con-
comitant with an increase in M. paratuberculosis specific IL-
10 production [5,6]. A comprehensive cytokine profile
has been reported for both circulating monocytes and
local tissues obtained from M. paratuberculosis-infected
cattle [7].
With a few notable exceptions [8-10], there is very little
data on antibody detection of M. paratuberculosis at early
stages of infection in cattle. There are several reasons for
this, but one in particular is that cattle that appear healthy
are not routinely evaluated using serial test bleeds and
analysis. Furthermore, there are numerous studies that
show the cell-mediated immune response in cattle pre-
dominates during the early stages of infection and is
responsible for the initial control of this infection
[4,6,11]. However, despite the lack of data describing the
temporal detection of specific antigens by host antibodies
early post infection, these experiments are critical to gain
a better understanding of the pathogenesis, diagnostics
and vaccine strategies for Johne's disease. For example, the
ideal diagnostic antigen would be detected early and
remain easily detected throughout the course of the dis-
ease. Alternatively, a good vaccine candidate antigen
might only be detectable by antibody at a specific stage of
the disease. Thus far, no such antigen has been discovered
for Johne's disease.
The recent literature has revealed an emphasis on devel-
oping consensus animal models for Johne's disease study.
One publication [12] is a result of an international meet-
ing, sponsored by the Johne's Disease Integrated Program
in the United States, which had the goal of proposing con-
sensus animal models for each of the commodity groups
including sheep and cattle as well as farmed deer in New
Zealand. Detailed methods including dose, route, length
of time for disease signs to appear, etc. were determined
[12]. A second communication, published independently
around the same time, provided similar information [13].
Prior to these comprehensive animal model reviews, we
published a study describing the intratonsillar route of
infection with M. paratuberculosis in neonatal calves [9].
Serial test bleeds were collected over the course of the 321-
day study and analyzed for T cell and B cell responses
using a variety of immunological assays. Selected test
bleeds from that study were used on the protein array in
the current study. The health status of these calves was fur-
ther monitored using additional tests, including fecal cul-
ture and IS900 PCR. Although M. paratuberculosis was
detected in all calves by 271 days post challenge, no clin-
ical signs were observed in any animal throughout the
study [9]. However, an antibody response was observed
by 134 days post infection using a lipoarabinomannan-
based ELISA test. A second study that evaluated an exper-
imental infection of goats observed an antibody response
as soon as 180 days post infection [14].
The study described herein combines the intratonsillar
infection model [9] with newly developed protein array
tools to obtain a temporal picture of antigen detection
during the initial year of infection in cattle. While the con-
cept of protein arrays has been around nearly as long as
the DNA array, there are very few protein arrays available.
This is because the process of constructing these arrays
involves the production of dozens of specific proteins, a
rate limiting and labor-intensive step when compared to
oligonucleotide synthesis used in constructing DNA
arrays. Nonetheless, studies using bacterial protein arrays
are beginning to appear in the literature [15-17] due to the
power provided by this tool for parallel protein analyses.
Our laboratory initially developed a 48 spot protein array
consisting of purified recombinant proteins representing
selected M. paratuberculosis gene products [18]. That array
was expanded to a 96-spot array and used in this study.
Results
Construction of a partial M. paratuberculosis protein 
array
A 96-spot protein array was constructed on nitrocellulose
filters using a dot blot apparatus to imprint the array. Rep-
resented among these spots are 92 M. paratuberculosis
recombinant fusion proteins including hypothetical pro-
teins (20), known antigens (6), membrane proteins (10),Proteome Science 2008, 6:5 http://www.proteomesci.com/content/6/1/5
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and proteins with no similarity in public sequence data-
bases (25). The affinity tag present within these recom-
binant fusion proteins is the maltose binding protein
(MBP). MBP was also expressed as a fusion with the E. coli
LacZ alpha peptide and used as a control to determine
antibody reactivity to this tag in each experiment. In addi-
tion, there are two spots that contain a sonicated whole
cell extract of M. paratuberculosis and one spot with only
spotting buffer as a negative control. A complete listing of
the proteins present on the array along with their sizes,
concentration and predicted function are listed in Table 1.
The performance of the array was tested using a mono-
clonal antibody developed to the MBP tag as shown pre-
viously [18]. These experiments showed that all proteins
containing the tag were readily detectable by immunoblot
analysis (data not shown).
Humoral immune response of experimentally infected 
cattle
An analysis of serial bleeds collected from two experimen-
tally infected calves was performed to temporally examine
the humoral immune response to the arrayed M. paratu-
berculosis  proteins. In general, the antibody response
against the set of 92 proteins was remarkably similar
between the two animals. One notable difference was that
fewer proteins were recognized at day 70 in animal 5904
compared to 5902, as only 11 proteins compared to 27
proteins were detected, respectively (Figure 1 and Figure
2). However by day 194, animal 5904 had antibodies
against more M. paratuberculosis proteins than did animal
5902. Serum from both animals detected similar numbers
of proteins at the end of the study period (Figure 1). The
pre-infection sera showed no detection of any of the
recombinant proteins (Figure 2) and there was no detec-
tion of the MBP-LacZ protein for all time points suggest-
ing that these calves do not have antibodies to the maltose
binding protein (MBP) affinity purification tag.
Temporal analysis of M. paratuberculosis proteins
The arrays exposed to cattle sera were analyzed by densit-
ometry to obtain a quantitative measure of antibody reac-
tivity (Table 2). When evaluating selected proteins over
the course of the study, certain trends in reactivity appear
to emerge for some proteins. For example, in both calves,
antibody reactivity declined between day 194 and day 321
for a group of 11 proteins. This was especially true for
MAP0862 and MAP2657, which showed the most severe
decline among these 11 proteins (Table 2). The seven pro-
teins that best fit into strong, moderate and weak response
categories are shown in Figure 3. While strong and mod-
erately detected proteins showed a wide range between
the calves at days 70 and 194, this range was considerably
reduced in the high category proteins at day 321 (Figure
3).
Identification of antigens detected early in M. 
paratuberculosis infection
Overall, the strongest antigen among this set of fusion
proteins was encoded by MAP1087 (Figures 2 and 3).
Antibody reactivity to this protein was observed in both
animals by day 70 and remained the strongest detected
protein throughout the course of the study (Figure 3 and
Table 2). MAP1204, a putative p60 homolog, was also
strongly detected by serum from both animals. Other
antigens identified in these studies include MAP1730c, a
putative ATP/GTP binding protein, and M. paratuberculosis
hypothetical sequences MAP0865 and MAP0961c.
MAP0865 contains the F57 DNA fragment which has pre-
viously been shown to be present uniquely in M. paratu-
berculosis [19] and resides on a 15.3 kb genomic island
termed large sequence polymorphism 4 (LSP4) [20], mak-
ing this protein an excellent candidate for use in a diag-
nostic test. Likewise, MAP0961c shows no sequence
similarity in nucleotide databases and is present on a 13.5
kb segment of the genome termed LSP5 [20]. However, a
similarity search of the SwissProt protein database reveals
a glycosyltransferase domain that may be involved in cell
envelope biogenesis. Furthermore, a corresponding
ortholog, termed MUL_4677, was found in the recently
published genome sequence of Mycobacterium ulcerans
[21]. Therefore, caution must be used if this protein were
to be considered for use in a diagnostic test. It is notewor-
thy that the whole cell sonicate antigen, which was spot-
ted in duplicate on the protein array (12E and 12H), was
not detected by either experimentally infected animal.
This same antigen preparation reacted very strongly to
anti-M. paratuberculosis sera from mice and rabbits previ-
ously [18]. In addition, two of three clinical cows showed
an antibody response to the whole cell sonicate antigen
[18] and hence it should be considered a potent prepara-
tion. This antigen preparation is likely similar to that used
in the ELISA test.
Early antigens are detected by sera from naturally infected 
cattle in the subclinical stage of Johne's disease
A panel of sera collected from 9 cows in the subclinical
stage of infection was analyzed by immunoblot against
the two strongest antigens identified from the protein
array experiments. These animals are housed at the
National Animal Disease Center and are monitored four
times a year for shedding of bacilli and immunological
status as measured by ELISA assays for antibody and IFN-
γ (Table 3). MAP1087 was detected in 4 of 9 serum sam-
ples (Figure 4, lanes 2–5) and very weakly reactive with
another 2 serum samples (Figure 4, lanes 7 and 8). Three
of the nine serum samples from the naturally infected
cows detected MAP1204. Serum from cow 183 detected
both MAP1087 and MAP1204 proteins. Likewise, serum
from cow 113 detected both proteins although weakly for
MAP1204. Neither antigen was detected by sera fromProteome Science 2008, 6:5 http://www.proteomesci.com/content/6/1/5
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Table 1: Mycobacterium avium subsp paratuberculosis proteins used in this study
Protein namea Concentration (mg/ml)b Gene sizec Amino acidsd Predicted function
MAP sonicate 1.0 NAe NA NA
MAP0075 0.18 423 140 conserved small membrane protein
MAP0087-his 1.0 717 238 probable secreted protein
MAP0105c 1.24 1058 352/889 hypothetical protein
MAP0182c 0.67 411 136 conserved hypothetical protein
MAP0216 1.66 1028 342/347 antigen 85A, mycolyltransferase
MAP0261c 0.49 465 154/161 19 kDa protein
MAP0389 2.04 947 315/337 diarylpropane peroxidase (EC 1.11.1.14) [Nostoc]
MAP0736 5.73 744 247 hypothetical protein
MAP0852 10.4 546 181 no BLAST hits
MAP0853 4.04 660 219 no BLAST hits
MAP0855 0.34 926 308/314 no BLAST hits
MAP0857c 0.70 318 105 hypothetical protein
MAP0858 0.44 537 178/182 no BLAST hits
MAP0859c 0.66 609 202 Mycobacterium phage L5
MAP0860c 0.04 885 294/296 no BLAST hits
MAP0861 0.43 342 113 no BLAST hits
MAP0862 0.48 989 329/360 no BLAST hits
MAP0863 0.66 675 224 no BLAST hits
MAP0864 7.42 426 141 no BLAST hits
MAP0865 0.08 1272 423 Hypothetical 30.9 kDa protein
MAP0866 3.07 804 267 integrase
MAP0904 0.81 371 124/246 conserved hypothetical protein
MAP0961c 0.18 719 239/352 hypothetical protein
MAP1087 0.43 441 146 prob. peptide transp. system permease, N-terminal
MAP1121c 0.32 498 165 putative substrate binding protein
MAP1174c 1.64 756 251 glucose-6-phosphate 1-dehydrogenase
MAP1204 2.61 735 244 putative exported p60 protein homologue
MAP1233 0.04 723 240 conserved hypothetical protein
MAP1345 0.69 600 199 no BLAST hits
MAP1388 0.08 396 131 no BLAST hits
MAP1416c 0.45 666 221 no BLAST hits
MAP1417c 0.54 435 144 no BLAST hits
MAP1609c 0.05 987 328/330 antigen 85B, mycolyltransferase
MAP1636c 1.12 425 141/157 no BLAST hits
MAP1643 0.45 2277 759/762 isocitrate lyase, [beta] module
MAP1655c 0.93 381 126 hypothetical protein
MAP1730c 0.26 1023 340 putative ATP/GTP-binding protein
MAP1931c 0.32 1104 367 anthranilate phosphoribosyltransferase
MAP2077c 1.66 330 109 hypothetical protein
MAP2116c 0.27 1269 422 cell invasion protein
MAP2121c 7.14 887 295/307 major membrane protein I
MAP2121c-his 0.99 924 307 major membrane protein I
MAP2151 2.79 438 145 no BLAST hits
MAP2155 9.57 312 103 similar to IS6110
MAP2156 0.59 963 320 putative transposase GEN: X52471)
MAP2157 0.38 1221 406 IS900
MAP2158 2.40 582 193 no BLAST hits
MAP2182c 0.26 435 144 conserved hypothetical protein
MAP2231 0.31 1422 473 PKS-associated protein, unknown function
MAP2360c 0.13 534 177 hypothetical protein
MAP2380 2.00 600 200/550 acyl-CoA synthase
MAP2657 0.26 651 216 putative oxidoreductase
MAP2663c 0.03 510 169 putative integral membrane protein
MAP2676c 1.30 354 117 hypothetical protein
MAP2734 0.37 1341 446 putative dioxygenasesdiooxygenases
MAP2740 0.24 666 221 putative membrane protein
MAP2751 0.70 582 193 no BLAST hits
MAP2753 0.17 309 103/252 hypothetical protein
MAP2761c 0.03 692 230/238 no BLAST hits
MAP2762c 1.45 425 141/146 no BLAST hitsProteome Science 2008, 6:5 http://www.proteomesci.com/content/6/1/5
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three of the cows tested (Figure 4, lanes 1, 6, and 9).
Finally, none of the sera from these animals detected the
protein encoded by MAP0858, a protein that was also not
detected by the experimentally infected cattle sera (Figure
2). These data suggest that MAP1087 and MAP1204 pro-
teins may be detectable in M. paratuberculosis-infected ani-
mals prior to the clinical stage of disease. In conclusion,
we hypothesize that while these antigens, if combined,
would recognized by 66% of the subclinical cows, addi-
tional antigen(s) need to be included along with
MAP1204 and MAP1087 in order to detect all nine sub-
clinical cows.
Discussion
Diagnosis of Johne's disease is difficult because as many
as 90% of infected animals may show no signs of disease
during sample collection and there is a lack of sensitive
and specific assays that detect M. paratuberculosis early dur-
ing infection. Antigen-based diagnostic tests for Johne's
disease currently use a complex mixture of antigens, such
as PPD or mycobacterial membrane fractions, that can
exhibit cross reactivity with other mycobacteria [22].
Results from this study further suggest that using complex
protein mixtures such as a whole cell sonicate extract may
not be as sensitive when compared to a few recombinant
proteins. This may be due to the heterogeneity of the son-
icated extract where each protein is present in very small
quantities. New scientific breakthroughs are expected
from the recently completed genome sequence of M.
paratuberculosis as this information now enables research-
ers to select and characterize M. paratuberculosis sequences
of interest. Our interest is in characterizing those
sequences that are novel and specific to M. paratuberculosis
in order to develop the best available diagnostic tools.
This study represents the most comprehensive M. paratu-
berculosis antigen analysis on a temporal scale. Data from
this study provide a first look at how specific antibody
reactivity changes over time and in direct comparison to
other proteins.
MAP2764c 0.10 290 96/149 no BLAST hits
MAP2765c 0.06 539 179/396 no BLAST hits
MAP2767c 0.42 473 157/183 no BLAST hits
MAP2963c 0.88 1499 499/874 no BLAST hits
MAP3084c-his 1.0 684 227 probable secreted protein
MAP3121 0.38 855 284 enoyl-CoA hydratase/isomerase superfamily
MAP3129 0.09 404 134/141 hypothetical protein
MAP3131 0.30 1096 365/942 conserved large membrane protein
MAP3155c 1.22 273 90 hypothetical protein
MAP3434 0.18 690 230/330 possible membrane protein
MAP3437c 0.29 843 279/280 no BLAST hits
MAP3531c 0.28 1034 344/352 antigen 85C, mycolytransferase
MAP3734c 0.19 1559 519/593 putative ABC transporter ATP-binding protein
MAP3735c 0.42 1181 393/429 part of heavy metal tolerance protein
MAP3743 0.85 998 332/348 hypothetical protein
MAP3751 0.11 879 293/979 conserved large membrane protein
MAP3753 0.64 1353 450 hypothetical protein
MAP3761c 0.07 729 242 conserved membrane protein
MAP3771 0.02 294 97 50S ribosomal protein L31
MAP3817c 0.65 939 312 no BLAST hits
MAP3833c 0.13 626 208/260 hypothetical protein
MAP3840 0.10 1872 623 70 kD heat shock protein, chromosome replication
MAP3902c 0.15 522 173 Serine/threonine kinase (EC 2.7.1.37) [Myc...
MAP3903c 0.42 531 176 Serine/threonine kinase (EC 2.7.1.37) [Myc...
MAP3954 0.05 279 92 conserved hypothetical protein
MAP4014 0.21 951 316 probable 4-amino butyrate transporter, N-terminal
MAP4025 0.32 854 284/325 cytochrome c-type biogenesis protein
MAP4129 0.26 965 321/336 ABC transporter
MAP4198 0.13 1283 427/441 SecY subunit of preprotein translocase
MAP4207c 5.28 686 228/231 probable ATP-binding transport protein
MAP4199 0.03 540/546 179/181 probable adenylate kinase
MAP4228 0.05 222 73 initiation factor IF-1
aProtein name corresponds to the genome project designation (Li et al., 2005). A second designation is included if known.
bProtein concentration is reported in as measured by Nanodrop spectrometry at 280nm.
cGene size is reported in base pairs (bp). In cases where only a portion of the M. avium subsp paratuberculosis gene was cloned, the number of bp present 
in the clone is reported first followed by the number of bp in the full-length M. avium subsp paratuberculosis gene.
dNumber of M. avium subsp paratuberculosis amino acids present in the fusion protein. In cases where only a portion of the M. avium subsp 
paratuberculosis protein is represented, the number of amino acids present is listed first followed by the total number of M. avium subsp paratuberculosis 
amino acids in the full-length protein.
eNA is not applicable.
Table 1: Mycobacterium avium subsp paratuberculosis proteins used in this study (Continued)Proteome Science 2008, 6:5 http://www.proteomesci.com/content/6/1/5
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When a temporal analysis of serial bleeds from experi-
mentally infected calves was undertaken, we discovered a
50-kDa protein that was detected by day 14 post-chal-
lenge and a 60-kDa protein was evident by day 42 [9].
However, these studies were performed with a whole cell
extract as the antigen and thus the identity of these early
antigens were never discovered. Nonetheless, these stud-
ies showed that a humoral immune response was initiated
in calves within a short time period following exposure to
M. paratuberculosis. The current study extends these initial
findings by using a recently developed protein array to
probe sera from these experimentally infected calves. The
two proteins that elicited the strongest antibody reactivity
were MAP1087, a probable peptide transport system per-
mease and MAP1204, a p60 protein homolog. These pro-
teins have a calculated size of 15.4 kDa and 25.4 kDa,
respectively. Therefore, it is unlikely that the proteins
encoded by MAP1087 and MAP1204 are the same 2 anti-
gens detected in the initial study by Waters et al [9].
Although MAP1204 is much more conserved across the
mycobacterial genus, both proteins are present as
orthologs in at least the genome sequences of M. smegma-
tis and M. avium strain 104. This raises the potential for
cross-reactivity if these antigens were incorporated into a
diagnostic test for Johne's disease.
A  M. paratuberculosis protein array was initially con-
structed from 43 recombinant proteins and tested with
sera from a variety of host species [18]. The protein array
has since been expanded to include a total of 92 recom-
binant proteins for the current study. Additional experi-
ments are planned that will use the protein array to
examine antibody profiles of subclinical cattle versus clin-
ical cattle. This study focused specifically on antigens
detected early following infection of cattle with M. paratu-
berculosis. Performing a test to detect M. paratuberculosis
antigens when clinical signs of the disease are already evi-
dent in the host, make the control of this disease by test
and cull strategies futile. An optimized serological test that
incorporates antigens detected at early times post-infec-
tion is a critical tool that animal producers/farmers need
to control Johne's disease. In this way infected animals
can be identified prior to shedding and exposure of herd
mates to the disease causing bacterium. Regarding unin-
fected cows, one key advantage of the experimental model
used is that each cow had its own animal-specific negative
control (the preinfection bleed). This type of control is
not available in most Johne's disease studies. In summary,
a highly specific test that could identify infected animals
within herds may have a greater and more immediate
impact on cattle industries than any other current man-
agement approach, including vaccination.
The ideal M. paratuberculosis protein antigen likely
remains undiscovered simply because all the proteins pro-
duced by M. paratuberculosis are not represented on the
current protein array. In this study, promising candidates
have been found, but the genome sequence annotation
suggests that M. paratuberculosis produces a total of 4,530
proteins [23]. Therefore, until a larger percentage of the
genome has been evaluated in a parallel manner similar
to this study, better antigens are still likely to be discov-
ered. Another limitation to using a protein array for anti-
gen discovery involves the identification of epitopes that
may be formed by multiple protein complexes. This pos-
sibility cannot be revealed when proteins are produced
and spotted in isolation such as on an array.
Our laboratory, in collaboration with others, has success-
fully completed the genome sequence of this significant
veterinary pathogen [23] and have used these data to
identify coding sequences specific to M. paratuberculosis.
Those studies have revealed less than 40 coding sequences
that are uniquely present in M. paratuberculosis [24,25].
This surprisingly small number of unique coding
sequences is primarily due to the genetic similarity among
members of the mycobacteria [26]. Among these coding
sequences, one gene, designated ISMAP02, is present in
six copies distributed randomly in the genome [25,27].
Furthermore, we have evaluated the expression products
from several of these M. paratuberculosis-specific sequences
for immunoreactivity with sera from animals exposed to
M. paratuberculosis [25,28]. Those studies identified pro-
teins encoded by MAP0862, MAP2963c and MAP3732c as
Total number of M. paratuberculosis recombinant proteins  detected by sera from experimentally infected cattle Figure 1
Total number of M. paratuberculosis recombinant proteins 
detected by sera from experimentally infected cattle. The graph 
shows the number of proteins on the 96-dot array (y-axis) that were 
detected at the day post infection (x-axis) for each calf. The total number 
of proteins detected is indicated on each bar. Note that similar numbers of 
proteins were detected by each animal at the end of the study period.Proteome Science 2008, 6:5 http://www.proteomesci.com/content/6/1/5
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potential diagnostic antigens. The newly constructed M.
paratuberculosis protein array has many of these same cod-
ing sequences represented. Both MAP0862 and
MAP2963c were detected in each animal in this study, but
MAP3732c is not present on the array used in the current
study. The antigens identified in this study should be fur-
ther evaluated with naturally infected animals in field tri-
als before incorporation into a diagnostic test for Johne's
disease.
Conclusion
Of the 92 recombinant M. paratuberculosis proteins ana-
lyzed in this study, 2 emerged as potential antigens for the
early detection of Johne's disease in cattle. These proteins
are encoded by MAP1087 and MAP1204. The combina-
tion of MAP1087 and MAP1204 detected more subclini-
cal cows than either protein alone, suggesting that the
ideal detection antigen will comprise a mixture of more
than one protein. Finally, this is a pilot scale study that
demonstrates the method is effective for use in a large-
scale antigen discovery project.
Methods
Animals
All cattle used in this study were housed at the National
Animal Disease Center (NADC) and handled using insti-
tutional care guidelines set by the animal care and use
committee. Experimentally infected calves were put in
biosafety level 2 containment immediately following
birth to prevent exposure to environmental mycobacteria.
Naturally infected subclinical cattle are contained on a
field pasture-barn set up on site at NADC. The experimen-
tally infected animals consisted of male Holstein calves
less than 1 year of age [9]. The health status and infection
procedure have been reported previously [9]. Briefly,
calves were infected with M. paratuberculosis by instillation
of four weekly doses of approximately 4 × 106 CFU (in 0.2
ml PBS) into both tonsillar crypts weekly from 2 to 5
Use of the dot blot protein array to obtain antibody reactivity profiles of experimentally infected calves Figure 2
Use of the dot blot protein array to obtain antibody reactivity profiles of experimentally infected calves. Shown are the spot assignments 
for the array (A) and dot blot arrays exposed to sera from experimentally infected calves (B). The time point for when each serum sample was collected is 
indicated in the margin beneath the images. The animal number is listed in the right margin. A whole cell lysate representing a majority of the proteins pro-
duced by M. paratuberculosis is spotted in E12 and H12 for all dot blots. Three proteins present on the upper right corner of the array (in column 12) are 
polyhistidine tagged proteins (MAP0087, MAP2121c and MAP3084c). The remaining 89 spots contain MBP fusion proteins of M. paratuberculosis coding 
sequences. Note that the MAP2121c coding sequence is represented twice on the array; once as an MBP fusion (spot F4) and also a polyhistidine tagged 
protein (12B).Proteome Science 2008, 6:5 http://www.proteomesci.com/content/6/1/5
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weeks of age. The subclinical cows used in this study com-
prised Holsteins, Brown Swiss and Guernsey with ages
that ranged from 2–7 years.
Protein array content
The protein array consists of a 96-dot format of proteins
spotted onto nitrocellulose. There are 92 total M. paratu-
berculosis proteins recombinantly produced in E. coli with
89 of these using the pMAL-c2 expression vector (New
England Biolabs), and 3 using the pET vector. All expres-
sion clones were sequenced to confirm that the cloned
insert matched the native M. paratuberculosis gene and was
in-frame with expression signals built into the expression
vector. One spot on the array contains the MBP/LacZ pro-
tein used as a control to assess antibody reactivity to the
MBP affinity tag. This control protein comprises the 42-
kDa maltose binding protein along with the 8-kDa LacZ
alpha peptide. Two spots contain a sonicated whole cell
extract of M. paratuberculosis prepared as described previ-
ously [9] and one spot contains the PBS spotting buffer
control only.
Protein array production
PBS was used as the spotting buffer and diluent for all M.
paratuberculosis proteins. All protein arrays were sequen-
tially produced and no single array was used for more
than one experiment. To print each array, the nitrocellu-
lose membrane, pre-soaked in PBS, was placed over a rub-
ber gasket such that it covered all wells of the Bio-dot 96-
well manifold apparatus (BioRad, Hercules, CA). The top
of the Bio-dot apparatus was then positioned over the
membrane and fastened in each corner. Each well was pre-
washed with 200 μl of PBS followed by a brief vacuum to
pull the buffer through the membrane. Diluted working
stocks of purified proteins were stored in deep 96-well
plates with a 1-ml capacity per round bottom well (Nal-
gene Nunc International). Transfer of these proteins from
the deep well plate to the assembled Bio-dot apparatus
was performed using an 8-channel multi-pipette. Each
well of the assembled 96-well dot blot apparatus was
loaded with the appropriate protein at a final concentra-
tion of 3 μg/well as measured in a NanoDrop spectropho-
tometer (Thermo Fisher Scientific) at 280nm. The PBS-
diluted samples were allowed to flow through the mem-
brane by gravity flow. Each well was rinsed with 200 μl of
PBS, 0.1% Tween-20 (TPBS). The vacuum was engaged to
pull the rinse solution through and the nitrocellulose
membrane was removed from the apparatus and placed in
a Petri dish containing a blocking solution (TPBS-BSA;
PBS with 2% bovine serum albumin, 0.1% Tween-20).
After 1 hour in the blocking solution, the immunoblot
assay was performed.
Immunoblot analysis of the protein array
Serum from M. paratuberculosis infected calves were
diluted in the blocking buffer and exposed to spotted
arrays for two hours at room temperature on a rocker plat-
form. All cattle sera were diluted 1:500. After three washes
Temporal trends of protein reactivity in experimentally infected cattle Figure 3
Temporal trends of protein reactivity in experimentally infected cattle. The lines show the average intensity for each protein over the course of 
the study period. The range observed between the two calves is indicated by statistical bars. Kernel Density Estimation performed on the log-transformed 
maximum intensity scores indicated there were three distinct normally distributed peaks. These distributions are statistically significant and define the pro-
teins belonging to the weak, moderate, or strong response groups. The graph labeled high contains the seven proteins most strongly detected by the cattle 
sera and the graph labeled low contains the seven proteins that showed the least reactivity with cattle sera. The seven proteins in the medium category are 
also representative of reactive antigens that either showed low reactivity initially or declining reactivity with time.Proteome Science 2008, 6:5 http://www.proteomesci.com/content/6/1/5
Page 9 of 12
(page number not for citation purposes)
Table 2: Spot intensities of proteins present on the array.a
Cow 5902 Cow 5904
Spot Locb Protein Day 0 Day 70 Day 194 Day 321 Day 0 Day 70 Day 194 Day 321
A7 MAP0075 0 4.472 21.431 21.122 0 0 27.612 21.36
A12 MAP0087-his 0.978 0 0 0 1.112 1.882 0 1.228
A5 MAP0105c 0 6.929 3.867 5.096 1.186 2.321 10.106 1.813
B5 MAP0182c 0 5.407 0 1.924 1.177 2.409 1.617 22.366
C4 MAP0216 0.652 3.779 1.296 1.395 2.175 3.444 0 0
G4 MAP0261c 2.395 2.287 3.487 5.668 1.097 3.146 2.397 2.496
E8 MAP0389 0 7.809 3.163 1.817 0 1.533 16.751 5.529
F8 MAP0736 0.734 0 0 0 0 0 1.446 0
A1 MAP0852 2.257 3.747 2.908 1.147 2.564 4.661 2.709 1.537
B1 MAP0853 2.144 3.734 5.095 8.497 1.961 4.158 3.239 2.649
C1 MAP0855 2.538 3.387 4.552 7.898 1.716 2.248 2.132 0
D1 MAP0857c 2.709 6.445 21.867 37.718 1.045 1.602 23.425 15.825
E1 MAP0858 3.005 3.882 1.775 3.999 1.978 0 0 0
F1 MAP0859c 2.821 4.137 2.87 3.745 1.909 0 2.803 0
G1 MAP0860c 2.996 0 5.531 12.743 1.592 0 7.669 6.676
H1 MAP0861 5.074c 0 3.407 3.053 1.546 4.05 3.111 3.52
A2 MAP0862 1.795 40.036 16.196 7.997 2.796 11.451 30.918 12.422
B2 MAP0863 1.518 5.524 3.174 4.592 2.057 4.891 3.274 1.473
C2 MAP0864 1.255 3.44 1.781 1.726 2.016 3.56 0 0
D2 MAP0865 1.909 18.708 32.138 44.846 1.317 4.386 31.361 35.251
E2 MAP0866 2.346 7.051 2.67 7.116 1.315 3.561 4.052 6.009
G8 MAP0904 1.678 0 0 0 0 0 0 0
G5 MAP0961c 1.797 14.366 26.5 37.546 0.78 2.103 33.046 42.877
A11 MAP1087 0.753 53.179 51.634 70.968 0.874 33.469 75.392 68.964
B11 MAP1121c 0.758 2.438 0 2.094 0.699 3.364 0 1.848
A10 MAP1174c 0 2.301 3.155 4.411 0.623 1.921 5.81 4.955
C11 MAP1204 0.78 40.8 43.856 55.046 0 28.367 61.122 58.985
F2 MAP1233 2.568 12.375 22.507 32.493 1.932 3.212 24.157 30.447
C5 MAP1345 0 3.339 1.861 1.018 1.147 0 3.413 2.389
D5 MAP1388 0 2.281 0 0 0.429 2.835 0 0
E5 MAP1416c 0 1.647 0 0 0.791 3.791 0 0
F5 MAP1417c 1.052 14.882 4.095 6.212 0.955 3.979 7.614 3.521
D4 MAP1609c 0.733 3.916 0 0 1.003 5.292 0 0
G2 MAP1636c 3.286 6.944 13.249 17.272 1.701 0 17.226 12.06
B4 MAP1643 0 4.155 0 1.534 1.827 0 0 0
H8 MAP1655c 2.788 0 0 0 0 2.049 0 0
G6 MAP1730c 1.147 29.831 43.872 52.35 0 12.272 57.799 57.47
B10 MAP1931c 0 2.917 0 2.217 0.511 2.886 2.077 3.339
H5 MAP2077c 3.833 0 2.784 9.443 1.385 0 3.63 9.221
D11 MAP2116c 1.418 29.88 33.215 42.633 0.568 11.24 51.336 47.918
F4 MAP2121c 1.76 4.158 1.373 1.513 0.969 3.005 0 0
B12 MAP2121c-his 1.247 0 0 0 0.889 2.172 21.226 2.155
H2 MAP2151 4.136 1.919 12.688 21.897 1.571 3.402 24.619 20.889
F12 MAP2155 2.434 0 1.385 0 1.251 2.039 0 2.105
G12 MAP2156 3.731 2.327 0 2.12 1.357 2.647 5.42 5.113
H6 MAP2157 3.504 0 0 0 0.751 1.532 1.51 2.683
A3 MAP2158 1.403 3.487 4.2 3.396 3.187 1.704 6.682 2.204
A9 MAP2182c 0 19.101 7.349 8.933 0 0 27.935 12.096
E11 MAP2231 1.846 3.732 11.54 15.671 1.166 0 17.203 18.933
B9 MAP2360c 0 3.168 0 0 0 2.766 0 0
C10 MAP2380 0.772 2.139 1.198 0 0 0 1.968 3.225
D10 MAP2657 0 22.372 8.29 3.68 0 15.937 39.178 25.032
B7 MAP2663c 0 9.594 3.661 2.248 0.868 0 4.9 2.717
A6 MAP2676c 0 3.291 1.406 0 0 0 2.036 0
D7 MAP2734 2.726 9.109 11.031 9.269 0 0 27.935 18.79
C7 MAP2740 0 1.736 6.447 18.061 0.507 0 6.295 10.804
B6 MAP2751 0 3.157 1.101 2.373 0.8 0 1.729 2.206
C6 MAP2753 0 1.909 0 2.176 0.624 0 1.701 2.585
D6 MAP2761c 0 0 0 0 0 0 0 0Proteome Science 2008, 6:5 http://www.proteomesci.com/content/6/1/5
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in TPBS, the nitrocellulose array was incubated for 1.5 h
with Horse Radish Peroxidase-conjugated anti-bovine IgG
antibody (Pierce) diluted at 1:20,000 in TPBS-BSA. This
was followed by a final three washes in TPBS. Assay devel-
opment was with SuperSignal detection reagents (Pierce)
and Kodak BioMax MR film.
Quantitative analysis of spot intensity
Spot intensity was measured using the Adobe Photoshop
CS3 extended application. This version has the ability to
record pixel gray values using the measurement scale of 1
pixel equals 1 pixel. Each spot was measured identically
using a window area of 1804 pixels. Values were exported
into a spreadsheet for further analysis. The background
statistics were calculated by determining the mean and
standard deviation of the 24 spots within each array that
had the least signal intensity. Each intensity score was
compared to the calculated background intensity. Values
that were within two standard deviations of the back-
ground mean were set to zero and all other intensity val-
ues were subtracted from the background mean to give
positive intensity values that were adjusted for the array
background. To determine the reactivity distribution of all
proteins in the complete set, the highest intensity score for
each protein was examined as a way to determine if there
was distinct stratification of maximal antibody response.
Kernel Density Estimation performed on the log-trans-
formed maximum intensity scores indicated there were
three distinct normally distributed peaks. These distribu-
tions define the proteins belonging to the low, medium,
or high reactivity groups presented in Figure 3.
E6 MAP2762c 0 0 0 0 0 2.397 0 0
B3 MAP2764c 1.472 2.739 1.969 5.874 2.13 5.442 2.039 1.955
H11 MAP2765c 4.816 0 0 0 0 4.799 0 0
C3 MAP2767c 1.257 3.507 2.303 7.019 1.982 4.347 1.92 2.722
F6 MAP2963c 0 0 0 0 0 2.204 0 0
C12 MAP3084c-his 1.313 0 0 0 0.999 2.026 0 1.982
E10 MAP3121 1.079 0 0 0 0 0 0 0
C9 MAP3129 1.406 2.366 0 1.206 0 0 1.731 2.865
E7 MAP3131 0 0 0 0 0 0 1.404 1.713
G11 MAP3155c 2.783 2.553 2.725 3.841 1.435 2.237 2.226 4.865
F7 MAP3434 0.832 1.401 8.312 19.522 0.508 0 33.289 14.418
D3 MAP3437c 1.674 3.321 1.29 1.587 1.359 1.965 0 0
E4 MAP3531c 0.926 7.373 2.472 4.313 0.558 2.834 1.374 0
G7 MAP3734c 1.085 2.238 2.719 17.809 0 0 10.914 20.81
E3 MAP3735c 1.944 4.897 5.078 18.618 1.326 3.368 3.887 4.502
F3 MAP3743 2.113 23.874 16.282 16.773 1.28 6.953 21.309 22.067
H7 MAP3751 2.991 0 0 0 0 0 2.499 3.033
D9 MAP3753 0 2.912 7.043 3.212 0 0 18.95 15.247
A8 MAP3761c 0 2.473 14.931 23.178 0 0 18.02 21.264
G3 MAP3771 2.81 2.229 1.344 2.528 0.953 1.997 0 0
H3 MAP3817c 3.836 2.526 10.298 22.826 1.101 1.552 15.736 19.901
E9 MAP3833c 1.078 0 2.07 2.755 0 0 3.676 4.636
A4 MAP3840 0.823 4.968 3.842 4.521 1.403 0 10.083 0
F9 MAP3902c 1.095 0 0 0 0 2.376 0 0
G9 MAP3903c 1.755 1.355 0 1.027 0 1.772 0 0
H9 MAP3954 3.426 0 0 1.969 0 7.584 1.612 3.629
F11 MAP4014 2.266 2.035 5.415 8.98 0.545 0 5.293 8.043
F10 MAP4025 1.474 25.139 34.876 39.022 0 13.413 49.655 47.012
B8 MAP4129 0 1.489 0 1.363 0 0 1.435 2.585
C8 MAP4198 0 1.536 1.517 6.817 0 0 5.431 6.175
G10 MAP4199 1.919 1.688 0 0 0.821 2.339 0 0
D8 MAP4207c 1.981 1.691 1.872 1.364 0 0 3.699 5.632
H10 MAP4228 4.373 0 0 0 0 3.122 0 0
H4 MBP-LacZ 4.128 0 0 1.722 1.303 0 0 0
D12 PBS bufferd 1.676 0 1.236 0 0.857 2.322 0 2.003
E12 Sonicatee 2.673 0 0 0 1.287 1.936 2.963 3.523
H12 Sonicate 5.01 1.359 0 0 1.366 4.337 3.002 4.472
aListed are the intensity values for each spot arranged by ascending MAP number. Measurements were made using a consistent 1804 pixel area circle to 
record spot density using the Adobe Photoshop CS3 Extended application.
bLoc is location on the dot blot array.
cThe strongest intensity for each time point is shown in bold.
dPBS buffer in spot D12 represents the spotting buffer only control.
eSonicate is a sonicated whole cell lysate of M. avium subsp paratuberculosis.
Table 2: Spot intensities of proteins present on the array.a (Continued)Proteome Science 2008, 6:5 http://www.proteomesci.com/content/6/1/5
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Slot immunoblot analysis of selected recombinant proteins  with serum from cattle in the subclinical stage of infection Figure 4
Slot immunoblot analysis of selected recombinant proteins with 
serum from cattle in the subclinical stage of infection. A prepara-
tive, single well gel was loaded with the protein indicated in the left margin 
and blotted onto nitrocellulose filters. The filters were placed into a slot 
blotting device and 1:500 dilutions of each cattle sera were loaded into 
independent slots. Each blot was further processed as described previ-
ously [29]. The positive control, indicated by the lane with a "+" sign above 
it, was probed with a monoclonal antibody developed against the MBP 
affinity tag as described previously [29]. These results demonstrate that 
MAP1087 and MAP1204 are detected by sera from naturally infected cat-
tle in the subclinical phase of infection. Serum sample slot assignments: 1, 
cow 85; 2, cow 112; 3, cow 113; 4, cow 117; 5, cow 183; 6, cow 235; 7, 
cow 834; 8, cow 871 and 9, cow 2715.
Table 3: Culture and immunological status of cattle used in this study.
IFN-γ (mg/ml)c
Cow ID Survey datea Fecal culture (CFU)b NS ConA MPS ELISA (S/P ratio)d
85 12/20/05 C, C, C, C 0.069 0.454 0.278 0.002
3/4/06 2, 2, 2 0.061 0.185 0.068 ND
112 12/20/05 C, C, 21, 1 0.07 0.218 0.064 0.027
4/10/06 2, 1, 1 0.063 1.83 0.09 0.014
113 8/10/04 C, C, C, C 0.21 0.514 0.054 0.041
11/10/04 0, 3, 1 0.39 1.51 0.54 0.09
117 12/17/04 T, T, T, T 0.053 0.143 0.097 -0.052
3/1/05 T, C, C 0.039 0.174 0.046 ND
183 12/20/05 0, 0, C, C 0.054 0.241 0.145 1.42
4/7/06 3, 2, 0 0.089 1.134 0.194 0.981
235 12/20/05 0, 0, 0, 0 0.068 0.362 0.114 0.039
3/4/06 0, 1, 1 0.05 0.35 0.064 0.021
834 8/10/04 0, 1, 0, 1 0.033 0.336 0.142 0.87
11/11/04 0, 0, 0 0.044 0.806 0.076 0.648
871 8/10/04 C, C, C, C 0.037 0.361 0.054 0.049
12/21/04 C, 2, 1 0.043 0.189 0.064 0.121
2715 12/20/05 2, 0, 1, 0 0.067 1.3 0.324 0.226
3/18/06 0, 0, 0 0.059 0.211 0.062 0.044
aEach animal is surveyed quarterly to monitor progression of Johne's disease. The two most recent quarterly surveys are shown for each animal, but 
only sera collected on the most recent date was used for the immunoblot assay in Figure 4.
bFecal culture is reported as numbers of colony forming units (CFU) present on each HYEM slant (platings are in triplicate or quadruplicate). A "C" 
indicates the slant had bacterial growth other than M. paratuberculosis. A "T" designation means too many colonies to count on that slant.
cThe gamma interferon (IFN-γ) assay. Subclinical cows typically have a M. paratuberculosis sonicate (MPS) reading higher than the no stimulation (NS) 
reading, along with little or no colonies on fecal culture slants. The concanavalin A (ConA) reading is a positive control as cells are readily stimulated by 
this lectin protein.
dThe ELISA sample to positive (S/P) ratio is calculated from the optical density reading as described previously [11].Publish with BioMed Central    and   every 
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